Goldencross Pharma Limited

A pharmaceutical company that develops, manufactures, and markets various medical products.

2000 | Thane, Maharashtra (India) | Active
Last Updated:

Goldencross Pharma Profile

Key Indicators

  • Authorised Capital ₹ 4.00 Cr
  • Paid Up Capital ₹ 0.46 M
  • Company Age 25 Year, 1 Month
  • Last Filing with ROC 31 Mar 2023
  • Satisfied Charges ₹ 91.50 Cr
  • Revenue Growth 0.89%
  • Profit Growth -6.56%
  • Ebitda -22.83%
  • Net Worth 6.97%
  • Total Assets 5.00%

About Goldencross Pharma

Goldencross Pharma Limited (GPL) is a leading Public Limited Indian Non-Government Company incorporated in India on 21 January 2000 and has a history of 25 years and one month. Its registered office is in Thane, Maharashtra, India.

The Corporate was formerly known as Goldencross Pharma Private Limited. The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 Cr and a paid-up capital of Rs 0.46 M.

The company has closed loans amounting to ₹91.50 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.

The Key Managerial Personnel (KMP) at Goldencross Pharma Limited India are Chirag Hotchandani as COMPANY SECRETARY and Pantha Kundu as Cfo. Dinesh Jain, Rajendra Chopra, Anisha Udeshi, and One other member serve as directors at the Company.

Company Details

  • Location

    Thane, Maharashtra, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

    cipla.com

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U24239MH2000PLC123766

  • Company No.

    123766

  • Company Classification

    Public Limited Indian Non-Government Company

  • Incorporation Date

    21 Jan 2000

  • Date of AGM

    22 Sep 2023

  • Date of Balance Sheet

    31 Mar 2023

  • Listing Status

    Unlisted

  • ROC Code

    Roc Mumbai

Industry

Pharma

Who are the key members and board of directors at Goldencross Pharma?

Executive Team (3)

NameDesignationAppointment DateStatus
Ujjwal Shendre Country flag representing In Managing Director24-May-2023Current
Chirag Hotchandani Company Secretary02-Feb-2022Current
Pantha Kundu CFO25-Aug-2023Current

Board Members (3)

NameDesignationAppointment DateStatus
Dinesh Jain Country flag representing In Director 14-Nov-2019Current
Anisha Udeshi Country flag representing In Director 08-Jun-2020Current
Rajendra Chopra Country flag representing In Director 03-Jan-2019Current

Financial Performance of Goldencross Pharma.

Goldencross Pharma Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 0.89% increase. The company also saw a slight decrease in profitability, with a 6.56% decrease in profit. The company's net worth moved up by a moderate rise of 6.97%.

Goldencross Pharma revenue growth over time
Goldencross Pharma profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
0.89%
Revenue from Operations
0.36%
Total Assets
5.00%
Profit or Loss
-6.56%
Net Worth
6.97%
EBITDA
-22.83%

What is the Ownership and Shareholding Structure of Goldencross Pharma?

In 2021, Goldencross Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹0

Satisfied Charges

₹91.50 Cr

Charges Breakdown by Lending Institutions

  • The Hongkong And Shanghai Banking Corporation Limited : 90.00 Cr
  • Credit Lyonnias : 1.50 Cr

Latest Charge Details

DateLenderAmountStatus
03 Feb 2009The Hongkong And Shanghai Banking Corporation Limited₹90.00 CrSatisfied
18 Mar 2002Credit Lyonnias₹7.50 MSatisfied
08 Mar 2002Credit Lyonnias₹7.50 MSatisfied

How Many Employees Work at Goldencross Pharma?

Goldencross Pharma has a workforce of 322 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee growth trends for Goldencross Pharma Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Goldencross Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Goldencross Pharma's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Goldencross Pharma

Recent activity within the organization

  • Annual General Meeting

    Goldencross Pharma Limited last Annual general meeting of members was held on 22 Sep 2023 as per latest MCA records.

  • Director Appointment

    Ujjwal Prakash Shendre was appointed as a Managing Director was appointed as a Managing Director on 24 May 2023 & has been associated with this company since 1 year 9 months .

  • Balance Sheet

    Goldencross Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai.

  • Director Appointment

    Chirag Hotchandani was appointed as a Company Secretary was appointed as a Company Secretary on 02 Feb 2022 & has been associated with this company since 3 years 1 month .

  • Director Appointment

    Anisha Naresh Udeshi was appointed as a Director was appointed as a Director on 08 Jun 2020 & has been associated with this company since 4 years 8 months .

  • Director Appointment

    Dinesh Ramniranjan Jain was appointed as a Director was appointed as a Director on 14 Nov 2019 & has been associated with this company since 5 years 3 months .

Recent News, Updates & Announcement

Frequently asked questions

  • What is the Incorporation or founding date of Goldencross Pharma Limited?

    Goldencross Pharma Limited was incorporated on 21 Jan 2000.

  • What is authorized share capital and paid-up capital of Goldencross Pharma Limited?

    The authorized share capital of Goldencross Pharma Limited is ₹ 4.00 Cr and paid-up capital is ₹ 0.46 M.

  • Who are the current board members & directors of Goldencross Pharma Limited?

    Currently 6 directors are associated with Goldencross Pharma Limited.

    • Dinesh Ramniranjan Jain
    • Rajendra Kumar Chopra
    • Anisha Naresh Udeshi
    • Ujjwal Prakash Shendre
    • Chirag Hotchandani
    • Pantha Milan Kundu

  • What is the registered address of Goldencross Pharma Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Goldencross Pharma Limited is Unit No.Sb-901 & Sb-902 Empire Tower Building, Gutno.31 Cloud City Campus Thane Belapur Rd Airoli, Navi Mumbai, Maharashtra, India, 400708.

  • What is the corporate identification number (CIN) and company number of Goldencross Pharma Limited?

    The corporate identification number (CIN) of Goldencross Pharma Limited is U24239MH2000PLC123766 and the company number is 123766 as per Ministry of Corporate Affairs (MCA).

  • What is the official website of Goldencross Pharma Limited?

    The Official website of Goldencross Pharma Limited is https://www.cipla.com

  • What has been the recent revenue trend for Goldencross Pharma Limited?

    According to the financial reports for the fiscal year 2023, the revenue trend for Goldencross Pharma Limited has risen by 0.89%.

  • How many employees does Goldencross Pharma Limited currently have?

    As Per 2023 financial reports, 322 employees are currently employed by Goldencross Pharma Limited.

  • What change has been observed in the net worth of Goldencross Pharma Limited, and by what percentage?

    The financial reports for the fiscal year 2023 indicates that The net worth of Goldencross Pharma Limited has experienced an upsurge of 6.97%.

  • When was the last Balance Sheet of Goldencross Pharma Limited filed with the ROC?

    The most recent Balance Sheet for Goldencross Pharma Limited was filed with the ROC on 31 Mar 2023.

People also Viewed

Similar Companies Based on Drug Formulation & Development